The global antibody discovery market is entering a high-growth phase, fueled by rapid innovation in antibody engineering, rising biologics investments, and increased collaboration between pharmaceutical companies and academic institutions. Valued at US$ 1.6 Bn in 2023, the market is projected to grow at a CAGR of 10.1% from 2024 to 2034, reaching approximately US$ 4.8 Bn by the end of 2034....

The antibody discovery market is emerging as a cornerstone of modern biopharmaceutical research, driven by the growing demand for targeted therapies, personalized medicine, and next-generation biologics. Antibody-based drugs have transformed the treatment landscape for cancer, autoimmune disorders, infectious diseases, and rare conditions, making antibody discovery a critical focus area for...